These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9767651)

  • 1. Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance.
    Bois F; Beney C; Boumendjel A; Mariotte AM; Conseil G; Di Pietro A
    J Med Chem; 1998 Oct; 41(21):4161-4. PubMed ID: 9767651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.
    Boumendjel A; Di Pietro A; Dumontet C; Barron D
    Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein.
    Manna F; Chimenti F; Fioravanti R; Bolasco A; Secci D; Chimenti P; Ferlini C; Scambia G
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4632-5. PubMed ID: 16099651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
    Fruttero R; Crosetti M; Chegaev K; Guglielmo S; Gasco A; Berardi F; Niso M; Perrone R; Panaro MA; Colabufo NA
    J Med Chem; 2010 Aug; 53(15):5467-75. PubMed ID: 20684594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
    Orlandi F; Coronnello M; Bellucci C; Dei S; Guandalini L; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Salerno M; Menif H; Bello I; Mini E; Teodori E
    Bioorg Med Chem; 2013 Jan; 21(2):456-65. PubMed ID: 23245571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
    Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines.
    Chiba P; Erker T; Galanski M; Hitzler M; Ecker GF
    Arch Pharm (Weinheim); 2002 May; 335(5):223-8. PubMed ID: 12210779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR-reversal activity of chalcones.
    Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
    In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New purines and purine analogs as modulators of multidrug resistance.
    Dhainaut A; Regnier G; Tizot A; Pierre A; Leonce S; Guilbaud N; Kraus-Berthier L; Atassi G
    J Med Chem; 1996 Sep; 39(20):4099-108. PubMed ID: 8831775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships.
    Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH
    ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
    Chiba P; Ecker G; Schmid D; Drach J; Tell B; Goldenberg S; Gekeler V
    Mol Pharmacol; 1996 Jun; 49(6):1122-30. PubMed ID: 8649352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
    Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
    Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.
    Zhang N; Zhang Z; Wong IL; Wan S; Chow LM; Jiang T
    Eur J Med Chem; 2014 Aug; 83():74-83. PubMed ID: 24952376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.